Announcement of the resolution by the Company's Board
of Directors for the ex-dividend record date
Date of events
2022/03/30
To which item it meets
paragraph 14
Statement
1.Date of the resolution by the board of directors or
shareholders' meeting, or of the decision by the company:2022/03/30
2.Type (ex-rights or ex-dividend) (please write "Ex-rights",
"Ex-dividend", or "Ex-rights and dividend"):Ex-dividend
3.Type and monetary amount of dividend distribution:
NT$380,615,000 (NT$5.0 per share)
4.Ex-rights (Ex-dividend) date:2022/04/21
5.Last date before book closure:2022/04/24
6.Book closure starting date:2022/04/25
7.Book closure ending date:2022/04/29
8.Ex-rights (Ex-dividend) record date:2022/04/29
9.Deadline for applying the conversion of the debt voucher:N/A
10.The closure period for the conversion of the debt voucher will
start from the date:N/A
11.The closure period for the conversion of the debt voucher will
end on the date:N/A
12.Payment date of cash dividend distribution:The expected distribution
date is May 13, 2022.
13.Any other matters that need to be specified:N/A
Attachments
Original Link
Original Document
Permalink
Disclaimer
Universal Vision Biotechnology Co. Ltd. published this content on 30 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 March 2022 13:52:08 UTC.
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD is a Taiwan-based company principally engaged in the trading of ophthalmic supplies and the provision of eye treatment and related medical services. The Company provides laser vision correction equipment and services, as well as the trading of medical drugs, optical glasses and contact lenses. In addition, the Company is involved in the leasing of medical places, the planning of clinic operation, as well as the provision of medical cosmetology services. The Company operates its businesses mainly in Taiwan market.
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD. 
